Chainalysis: Peptide suppliers in the grey market are increasingly using Bitcoin and stablecoins
Odaily reported that Chainalysis released a report stating that as the demand for grey-market peptide products (such as weight-loss drugs like semaglutide) grows rapidly, relevant suppliers and buyers are increasingly using cryptocurrency for transactions, with major suppliers mainly relying on Bitcoin and stablecoins.
The report shows that in the first quarter of 2026, crypto funds flowing into this sector reached 32 million US dollars, representing a 159% increase from the previous quarter’s 12 million US dollars. The annualized volume has already exceeded 100 million US dollars.
Chainalysis pointed out that demand for peptide products is driven by cosmetic medicine, health and wellness trends, and the popularity of GLP-1 drugs. However, as these products often involve prescription-grade compounds or unregulated substances, traditional banks and credit card processors typically restrict such transactions, prompting the market to shift to crypto payments.
The organization also noted that some leading suppliers have adopted more professional on-chain fund management methods. Especially among suppliers with an average transaction deposit over 1,000 US dollars, the share of stablecoins has increased significantly, which may be to reduce the risk of large supply chain orders being affected by crypto market volatility.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Deutsche Bank: Changes in Investor Positions and Capital Flows
New Generation of Crypto Miners Released by ASICID
BUZZ - Levi Strauss shares drop due to weak sales in the US and Europe
On October 8, Levi Strauss (LEVI.N) shares fell 1.3% in pre-market trading to $19.25 after the company reported lower-than-expected sales in the U.S. and Europe. BTIG commented: “This quarter, the European direct-to-consumer (DTC) business was hit by unusually warm weather, but as temperatures return to normal, foot traffic and sales trends have improved, maintaining a positive outlook in early Q4.” The brokerage also noted that the company remains strong in wholesale, e-commerce, and market share in jeans, but its “back-to-school” marketing campaign did not meet expectations. Benefiting from tariff refunds on Wednesday, the company raised its annual profit forecast and is betting on strong demand for its premium jeans and sweaters during the holiday season. Sixteen analysts have an average “buy” rating; the median price target is $27, according to LSEG. The stock has risen 6% year-to-date as of the previous close.
Oil: Prices supported by supply risks and Iran tensions – Danske Bank
Crypto prices
More
